Abstract
The US blood supply is once again expanding (14 million units a year) and annual estimated whole blood and red blood cell (RBC) transfusion now exceeds 12 million units. The observed increase in total transfusions and units transfused per surgical procedure may result from more aggressive therapies, an aging population, and improved access to health care. While autologous blood collection has grown 20-fold in the past decade, autologous blood still accounts for
Original language | English (US) |
---|---|
Pages (from-to) | 123-135 |
Number of pages | 13 |
Journal | Artificial Cells, Blood Substitutes, and Biotechnology |
Volume | 22 |
Issue number | 2 |
DOIs | |
State | Published - 1994 |
Externally published | Yes |
ASJC Scopus subject areas
- Biomedical Engineering
- Biotechnology
- Biomaterials
- Hematology